Archive for 'Tag Archives: 'UCL''
Rosellini Scientific Benelux SA Joins Walloon Region Consortium to Help Develop Implant System for Glaucoma Treatment
An exciting new medtech player in Belgium’s Walloon Region – Rosellini Scientific Benelux SA (RSB) – joins the consortium to develop a novel implant system for treating and monitoring glaucoma. The 4-partner consortium, led by iSTAR [...]
An article in the Japanese press is praising the quality of research in cellular therapy at the UCL within the laboratory of Prof. Etienne Sokal and at Louvain-born spin-off Promethera Biosciences. The article on regenerative medicine, [...]
New research on obesity and diabetes led by Professor Patrice D. Cani, research associate of the FRS-FNRS at the Louvain Drug Research Institute (UCL) and investigator for WELBIO (UCL), has recently been published in the prestigious [...]
Belgian Yves Jongen: one of the three nominees for the European Inventor lifetime achievement Award for proton therapy cancer treatment
Yves Jongen a true pioneer in the domain of proton therapy was selected as one of the three nominees for the European Inventor lifetime achievement Award for his development of proton therapy to cure cancer. With his [...]
DNAlytics, a Belgian-based SME, introduces new diagnostic solution to help rheumatologists and orthopedic surgeons identify rheumatoid arthritis at the early onset
In keeping in line with their intent to develop a culture of innovation with a focus on the patient; and to be the reference partner in data analysis for predictive and personalized medicine for the European [...]
DNAlytics welcomes new customers after receiving official “UCL spin-off” label and support from the Caring Entrepreneurship Fund.
Founded in April 2012 by Prof. Pierre Dupont and Dr. Thibault Helleputte, privately held company DNAlytics(Louvain-la-Neuve, Belgium) has recently become a new spin-off of the Université Catholique de Louvain (UCL). During the summer of 2012 a [...]
Foundation Fournier-Majoie Award given to Prof. Gallez and his team at UCL (Louvain, Belgium) for developing way to measure tumor oxygenation.
Prof. Bernard Gallez, recognized internationally for his expertise in tissue oxygenation measurements, has recently been granted, along with his team from the Catholic University of Louvain, the Foundation Fournier-Majoie (FFM) award for their development of a [...]
Nanomedicine expert LDRI (UCL, Belgium) partners in European program to find oral alternative for Diabetics.
The Louvain Drug Research Institute (LDRI) of the Catholic University of Louvain (UCL), expert in nanomedecine, is participating in a new European program in a fight against diabetes. The aim is to develop new methods of [...]